Viewing Study NCT03659435


Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2026-01-07 @ 7:11 AM
Study NCT ID: NCT03659435
Status: COMPLETED
Last Update Posted: 2019-09-19
First Post: 2018-08-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)
Sponsor: SocraTec R&D GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module